- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 6 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 4 residues within 4Å:- Chain G: N.204, T.206, P.208, H.321
1 PLIP interactions:1 interactions with chain G- Hydrophobic interactions: G:T.206
NAG-NAG.5: 4 residues within 4Å:- Chain I: N.204, T.206, P.208, H.321
1 PLIP interactions:1 interactions with chain I- Hydrophobic interactions: I:T.206
NAG-NAG.8: 4 residues within 4Å:- Chain K: N.204, T.206, P.208, H.321
1 PLIP interactions:1 interactions with chain K- Hydrophobic interactions: K:T.206
- 36 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.10: 5 residues within 4Å:- Chain G: Q.100, S.120, F.121, N.122, K.133
Ligand excluded by PLIPNAG.11: 1 residues within 4Å:- Chain G: N.103
Ligand excluded by PLIPNAG.12: 2 residues within 4Å:- Chain G: N.271, V.410
Ligand excluded by PLIPNAG.13: 4 residues within 4Å:- Chain G: N.265, T.267, H.299, N.301
Ligand excluded by PLIPNAG.14: 3 residues within 4Å:- Chain G: P.261, N.416
- Ligands: NAG-NAG-BMA.1
Ligand excluded by PLIPNAG.15: 3 residues within 4Å:- Chain G: S.357, F.360, N.361
Ligand excluded by PLIPNAG.16: 1 residues within 4Å:- Chain G: N.355
Ligand excluded by PLIPNAG.17: 3 residues within 4Å:- Chain G: E.57, N.58
- Chain H: S.17
Ligand excluded by PLIPNAG.18: 5 residues within 4Å:- Chain G: V.104, N.118, Y.135, L.137, D.290
Ligand excluded by PLIPNAG.19: 1 residues within 4Å:- Chain H: N.114
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain H: N.107, S.109, E.110
Ligand excluded by PLIPNAG.21: 1 residues within 4Å:- Chain H: N.126
Ligand excluded by PLIPNAG.22: 5 residues within 4Å:- Chain I: Q.100, S.120, F.121, N.122, K.133
Ligand excluded by PLIPNAG.23: 1 residues within 4Å:- Chain I: N.103
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain I: N.271, V.410
Ligand excluded by PLIPNAG.25: 4 residues within 4Å:- Chain I: N.265, T.267, H.299, N.301
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain I: P.261, N.416
- Ligands: NAG-NAG-BMA.4
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain I: S.357, F.360, N.361
Ligand excluded by PLIPNAG.28: 1 residues within 4Å:- Chain I: N.355
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain I: E.57, N.58
- Chain J: S.17
Ligand excluded by PLIPNAG.30: 5 residues within 4Å:- Chain I: V.104, N.118, Y.135, L.137, D.290
Ligand excluded by PLIPNAG.31: 1 residues within 4Å:- Chain J: N.114
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain J: N.107, S.109, E.110
Ligand excluded by PLIPNAG.33: 1 residues within 4Å:- Chain J: N.126
Ligand excluded by PLIPNAG.34: 5 residues within 4Å:- Chain K: Q.100, S.120, F.121, N.122, K.133
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain K: N.103
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain K: N.271, V.410
Ligand excluded by PLIPNAG.37: 4 residues within 4Å:- Chain K: N.265, T.267, H.299, N.301
Ligand excluded by PLIPNAG.38: 4 residues within 4Å:- Chain K: N.232, P.261, N.416
- Ligands: NAG-NAG-BMA.7
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain K: S.357, F.360, N.361
Ligand excluded by PLIPNAG.40: 1 residues within 4Å:- Chain K: N.355
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain K: E.57, N.58
- Chain L: S.17
Ligand excluded by PLIPNAG.42: 5 residues within 4Å:- Chain K: V.104, N.118, Y.135, L.137, D.290
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain L: N.114
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain L: N.107, S.109, E.110
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain L: N.126
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yang, S. et al., Dynamic HIV-1 spike motion creates vulnerability for its membrane-bound tripod to antibody attack. Nat Commun (2022)
- Release Date
- 2022-11-09
- Peptides
- 4E10 Fab light chain: ACE
4E10 Fab heavy chain: BDF
Envelope glycoprotein gp120: GIK
Transmembrane protein gp41: HJL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
HC
NE
MB
GD
KF
IG
AI
CK
EH
BJ
DL
F
SMTL ID : 7sd3.1
Cytoplasmic tail deleted HIV-1 Env bound with three 4E10 Fabs
4E10 Fab light chain
Toggle Identical (ACE)4E10 Fab heavy chain
Toggle Identical (BDF)Envelope glycoprotein gp120
Toggle Identical (GIK)Transmembrane protein gp41
Toggle Identical (HJL)Related Entries With Identical Sequence
1tzg.1 | 1tzg.2 | 1tzg.3 | 2fx7.1 | 2fx8.1 | 2fx8.2 | 2fx8.3 | 2fx8.4 | 2fx9.1 | 2fx9.2 | 4tvp.1 | 4wy7.1 | 4xaw.1 | 4xbe.1 | 4xbg.1 | 4xbg.2 | 4xbg.3 | 4xbg.4 | 4xbg.5 | 4xbg.6 | 4xbp.1 | 4xbp.2 | 4xbp.3 | 4xbp.4 | 4xc1.1 | 4xc3.1 | 4xcc.1 | 4xce.1 | 4xce.2 | 4xce.3 more...less...4xcn.1 | 4xcn.2 | 4xcn.3 | 4xcn.4 | 4xcn.5 | 4xcn.6 | 4xcy.1 | 4xcy.2 | 4xcy.3 | 4xcy.4 | 4xcy.5 | 4xcy.6 | 4zmj.1 | 5fyl.1 | 5i8h.1 | 5i8h.2 | 5t3x.1 | 5t3z.1 | 5thr.1 | 5u7m.1 | 5u7o.1 | 5v8l.1 | 5v8m.1 | 5viy.1 | 5vj6.1 | 5x08.1 | 6cm3.1 | 6did.1 | 6oz4.1 | 6u0l.1 | 7ekb.1 | 7pc2.1 | 7txd.1 | 7uoj.1 | 8jtd.1 | 8jtm.1 | 8ttw.1